Meta-analysis of selected toxicity endpoints of CDK4/6 inhibitors: Palbociclib and ribociclib

R. Costa, R. B. Costa, Sarah M. Talamantes, Irene Helenowski, Jonna Peterson, Jason Kaplan, B. A. Carneiro, Francis J. Giles, W. J. Gradishar

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalBreast
Volume35
DOIs
StatePublished - Oct 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Surgery
  • Oncology
  • Cancer Research

Keywords

  • Infection
  • Neutropenia
  • Palbociclib
  • Ribociclib

Cite this